Literature DB >> 8957383

Rebound pulmonary hypertension after inhalation of nitric oxide.

A M Atz1, I Adatia, D L Wessel.   

Abstract

BACKGROUND: We describe the hemodynamic response to initiation and withdrawal of inhaled nitric oxide (NO) in infants with pulmonary hypertension after surgical repair of total anomalous pulmonary venous connection.
METHODS: Between January 1, 1992, and January 1, 1995, 20 patients underwent repair of total anomalous pulmonary venous connection. Nine patients had postoperative pulmonary hypertension and received a 15-minute trial of inhaled NO at 80 parts per million. Five of these patients received prolonged treatment with NO at 20 parts per million or less.
RESULTS: Mean pulmonary artery pressure decreased from 35.6 +/- 2.4 to 23.7 +/- 2.0 mm Hg (mean +/- standard error of the mean) (p = 0.008), and pulmonary vascular resistance decreased from 11.5 +/- 2.0 to 6.4 +/- 1.0 U.m2 (p = 0.03). After prolonged treatment with NO, pulmonary artery pressure increased transiently in all patients when NO was discontinued.
CONCLUSIONS: After operative repair of total anomalous pulmonary venous connection, inhaled NO selectively vasodilated all patients with pulmonary hypertension. Withdrawal of NO after prolonged inhalation was associated with transient rebound pulmonary hypertension that dissipated within 60 minutes. Appreciation of rebound pulmonary hypertension may have important implications for patients with pulmonary hypertensive disorders when interruption of NO inhalation is necessary or when withdrawal of NO is planned.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8957383     DOI: 10.1016/s0003-4975(96)00542-5

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  24 in total

Review 1.  Inhaled nitric oxide and pulmonary vasoreactivity.

Authors:  M Aranda; R G Pearl
Journal:  J Clin Monit Comput       Date:  2000       Impact factor: 2.502

Review 2.  Reactive oxygen and nitrogen species in pulmonary hypertension.

Authors:  Diana M Tabima; Sheila Frizzell; Mark T Gladwin
Journal:  Free Radic Biol Med       Date:  2012-03-06       Impact factor: 7.376

3.  Regulation of nitric oxide consumption by hypoxic red blood cells.

Authors:  Tae H Han; Erion Qamirani; Allyson G Nelson; Daniel R Hyduke; Gautam Chaudhuri; Lih Kuo; James C Liao
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-01       Impact factor: 11.205

Review 4.  Severe paediatric pulmonary hypertension: new management strategies.

Authors:  A Rashid; D Ivy
Journal:  Arch Dis Child       Date:  2005-01       Impact factor: 3.791

5.  A European survey of the use of inhaled nitric oxide in the ICU. Working Group on Inhaled NO in the ICU of the European Society of Intensive Care Medicine.

Authors:  S Beloucif; D Payen
Journal:  Intensive Care Med       Date:  1998-08       Impact factor: 17.440

6.  Attenuated vasodilatation in lambs with endogenous and exogenous activation of cGMP signaling: role of protein kinase G nitration.

Authors:  Saurabh Aggarwal; Christine M Gross; Sanjiv Kumar; Sanjeev Datar; Peter Oishi; Gokhan Kalkan; Christian Schreiber; Sohrab Fratz; Jeffrey R Fineman; Stephen M Black
Journal:  J Cell Physiol       Date:  2011-12       Impact factor: 6.384

Review 7.  Inhaled nitric oxide in neonates.

Authors:  N Finer
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-09       Impact factor: 5.747

Review 8.  Pharmacologic management of perioperative pulmonary hypertension.

Authors:  Julie W Cheng; Adriano R Tonelli; Gosta Pettersson; Richard A Krasuski
Journal:  J Cardiovasc Pharmacol       Date:  2014-04       Impact factor: 3.105

9.  GTP cyclohydrolase I expression is regulated by nitric oxide: role of cyclic AMP.

Authors:  Sanjiv Kumar; Xutong Sun; Shruti Sharma; Saurabh Aggarwal; Kandasamy Ravi; Jeffery R Fineman; Stephen M Black
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-05-15       Impact factor: 5.464

10.  Postoperative use of oral sildenafil in pediatric patients with congenital heart disease.

Authors:  Ju Yeon Uhm; Won-Kyoung Jhang; Jeong-Jun Park; Dong-Man Seo; Sung-Cheol Yun; Tae-Jin Yun
Journal:  Pediatr Cardiol       Date:  2010-01-07       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.